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with excellent external and internal validity.1 Excellent
external validity tells us that in the end, surgeons are moti-
vated to enter cases and procedures into a registry, and good
internal validity tells us that they even ﬁll in the information
correctly. In the current validation carried out in Denmark,
the seven hospitals that were included in the detailed vali-
dation covered 51% of the carotid and 78% of the aortic
procedures performed in the entire country. Remarkable
external (99%) and internal (96%) validity was found. Indeed,
the data quality in the Karbase registry was clearly superior
to local administrative data e the same phenomenon was
observed in the validation of SwedVasc. A commonly heard
opinion on registry based studies is somewhat dismissive:
“Well, it is based on a registry, and registry data are more or
less incorrect.” I think we can agree that this is not the case
with the Danish vascular registry. Furthermore, in the two
earlier validations of the SwedVasc and the Hungarian
vascular registries, the vascular registry validity results have
been very good.2,3 All these validations have been made on
carotid endarterectomies and repair of abdominal aortic
aneurysms, which should be kept in mind.
The validity of a vascular registry depends on one thing:
the motivation of the vascular surgeon to contribute to the
registry. Where does that motivation come from? One of
the most important issues is the feedback from the registry.
At its best, a vascular registry gives online feedback to the
individual surgeon on his or her performance in relation to
the average and the commonly agreed standards, and the
external validity of the registry is evaluated regularly. In the
worst scenario, the individual surgeon does not receive any
feedback from the registry, nor is the external validity under
continuous scrutiny. It is easy to imagine which of these
scenarios leads to a more valid registry. In order to achieve
a balanced environment for a well functioning vascular
registry, it is as important to develop the reporting tools as
it is to develop the registry itself. This, in turn, requires in-
terest by the hospital to invest in the registry, in addition to
an enthusiastic person in the hospital advocating the reg-
istry among vascular surgeons.* Corresponding author. Department of Vascular Surgery, University of
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10.1016/j.ejvs.2019.06.025Building a vascular registry is challenging. Which variables
should be included and how many alternative answers
offered? In this phase, it is tempting to include everything
and every possible detailed answer in the toolbox. A good
example would be the information regarding smoking. At
their simplest, the choices are yes and no. However, at this
stage, many may think that the registry naturally has to
include information about past smoking. But how far back
in the patient’s history does “past smoking” apply to? And
what about the number of packs of cigarettes the patient
smokes? Continuing along these lines, you may end up with
six different choices regarding smoking. It is easy to un-
derstand how this may inﬂuence the validity of the smoking
data in the registry. It has been neatly shown that the more
choices you have, the poorer the validity.
The International Consortium for Vascular Registries used
the Delphi approach to achieve a consensus on the mini-
mum core dataset of registries devoted to peripheral arte-
rial revascularisation.4 From what was originally 187 items
in eight categories (patient characteristics, comorbidities,
current medications, procedure, complications), 79 were
eventually included. This paper gives valuable information
for the registries to achieve the optimal data set and also to
harmonise the registry infrastructure and the deﬁnitions of
items in existing registries. Furthermore, Vascunet is pre-
paring to publish the registry reporting standards that will
help to harmonise the existing registries and give guidance
for new registries in the planning of the data collection.
In the end, I thinkwe can all agree that a vascular registry is a
tool that every vascular surgeon should have at their disposal.
We have seen that an acceptable reliability can be achieved!
The validations of Vascunet registries will continue during the
coming years, thanks to the European Society of Vascular Sur-
gerywhichhasbeenwillingtoﬁnancethese importantprojects.REFERENCES
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